K Singh, G Garg, V Ali - Current drug metabolism, 2016 - ingentaconnect.com
Leishmaniasis is one of the six diseases regarded most neglected by World Health Organization which is predominant in developing countries. Clinically, among the different …
A Weingärtner, G Kemmer, FD Müller, RA Zampieri… - 2012 - journals.plos.org
The protozoan parasite Leishmania is an intracellular pathogen infecting and replicating inside vertebrate host macrophages. A recent model suggests that promastigote and …
Visceral leishmaniasis (VL), the second-most dreaded parasitic disease after malaria, is currently endemic in 88 countries. Dramatic increases in the rates of infection, drug …
Aims Recently, strategies of cancer treatment using combination of agents with distinct molecular mechanism (s) of action are considered more promising due to its high efficacy …
M Islamuddin, D Sahal, F Afrin - Journal of medical …, 2014 - microbiologyresearch.org
Leishmaniasis consists of a complex spectrum of infectious diseases with worldwide distribution of which visceral leishmaniasis or kala-azar caused by Leishmania donovani is …
Leishmaniasis is a severe public-health problem, with high rates of morbidity and mortality. Efforts to find new, effective and safe oral agents for the treatment of leishmaniasis have …
S Kaushik, H Shyam, R Sharma, AK Balapure - Phytomedicine, 2018 - Elsevier
Background Despite advancements in the prognosis and management of breast cancer, it remains a major cause of mortality in women worldwide. Centchroman (CC), an oral …
B Gawdzik, P Kowalczyk, D Koszelewski, A Brodzka… - Membranes, 2022 - mdpi.com
Herein, we present biological studies on 3, 4-dihydropyrimidin-2 (1H)-ones (DHPMs) obtained via Biginelli reaction catalyzed by NH4Cl under solvent-free conditions. Until now …
Abstract Pyrido [2, 3‐d] pyrimidine‐2, 4 (1H, 3H)‐diones were synthesized, for the first time, from indole chalcones and 6‐aminouracil, and their ability to inhibit leishmaniasis and …